Amdocs (NASDAQ:DOX) Hits New 52-Week Low – Time to Sell?

Amdocs Limited (NASDAQ:DOX) shares reached a new 52-week low on Wednesday . The company traded as low as $69.47 and last traded at $69.69, with a volume of 357819 shares changing hands. The stock had previously closed at $73.13.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DOX. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Stifel Nicolaus lowered their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Barclays dropped their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Finally, Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Stock Up 1.3%

The stock has a 50-day moving average price of $79.63 and a 200-day moving average price of $81.77. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17. The company has a market capitalization of $7.47 billion, a P/E ratio of 13.39, a P/E/G ratio of 1.21 and a beta of 0.40.

Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the prior year, the firm posted $1.66 EPS. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, research analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be paid a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.3%. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio (DPR) is presently 43.91%.

Institutional Investors Weigh In On Amdocs

A number of hedge funds have recently added to or reduced their stakes in DOX. William Blair Investment Management LLC boosted its holdings in shares of Amdocs by 2.4% during the 2nd quarter. William Blair Investment Management LLC now owns 5,650 shares of the technology company’s stock worth $516,000 after buying an additional 133 shares in the last quarter. Mutual Advisors LLC boosted its stake in Amdocs by 3.2% during the second quarter. Mutual Advisors LLC now owns 4,516 shares of the technology company’s stock worth $397,000 after acquiring an additional 138 shares in the last quarter. MGO One Seven LLC grew its holdings in Amdocs by 5.1% in the second quarter. MGO One Seven LLC now owns 2,899 shares of the technology company’s stock worth $264,000 after purchasing an additional 140 shares during the period. Scotia Capital Inc. grew its holdings in Amdocs by 3.5% in the third quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares during the period. Finally, Huntington National Bank increased its stake in Amdocs by 5.0% in the second quarter. Huntington National Bank now owns 3,273 shares of the technology company’s stock valued at $299,000 after purchasing an additional 155 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.